Patents by Inventor Mohammad Hassan Beyzavi

Mohammad Hassan Beyzavi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for deoxyfluorination of phenols
    Patent number: 11046628
    Abstract: The present invention refers to a process for transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: June 29, 2021
    Assignee: STUDIENGESELLSCHAFT KOHLE MBH
    Inventors: Tobias Ritter, Constanze Neumann, Mohammad Hassan Beyzavi, Martin Georg Strebl-Bantillo, Debashis Mandal
  • PROCESS FOR DEOXYFLUORINATION OF PHENOLS
    Publication number: 20200369583
    Abstract: The present invention refers to a process for transition-metal-assisted 18F-deoxyfluorination of phenols. The transformation benefits from readily available phenols as starting materials, tolerance of moisture and ambient atmosphere, large substrate scope, and translatability to generate doses appropriate for positron emission tomography (PET) imaging.
    Type: Application
    Filed: July 10, 2018
    Publication date: November 26, 2020
    Applicants: STUDIENGESELLSCHAFT KOHLE MBH, PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Tobias RITTER, Constanze NEUMANN, Mohammad Hassan BEYZAVI, Martin Georg STREBL-BANTILLO, Debashis MANDAL
  • Gold(I) And Platinum(II) With Isocyanide Ligand Complexes: Synthesis And Biological Activity
    Publication number: 20200215018
    Abstract: A method of treating cancer which comprises administering to a cancer patient a therapeutically effective amount of a gold or platinum based drug that has less toxicity and a different mechanism of action to kill the tumor cells than cisplatin.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 9, 2020
    Applicant: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
    Inventors: Mohammad Hassan Beyzavi, Hamid Reza Shahsavari